首页> 美国卫生研究院文献>Journal of Clinical Medicine >Platelet Counting: Ugly Traps and Good Advice. Proposals from the French-Speaking Cellular Hematology Group (GFHC)
【2h】

Platelet Counting: Ugly Traps and Good Advice. Proposals from the French-Speaking Cellular Hematology Group (GFHC)

机译:血小板计数:陷阱陷阱和良好建议。法语细胞血液学小组(GFHC)的提案

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Despite the ongoing development of automated hematology analyzers to optimize complete blood count results, platelet count still suffers from pre-analytical or analytical pitfalls, including EDTA-induced pseudothrombocytopenia. Although most of these interferences are widely known, laboratory practices remain highly heterogeneous. In order to harmonize and standardize cellular hematology practices, the French-speaking Cellular Hematology Group (GFHC) wants to focus on interferences that could affect the platelet count and to detail the verification steps with minimal recommendations, taking into account the different technologies employed nowadays. The conclusions of the GFHC presented here met with a "strong professional agreement" and are explained with their rationale to define the course of actions, in case thrombocytopenia or thrombocytosis is detected. They are proposed as minimum recommendations to be used by each specialist in laboratory medicine who remains free to use more restrictive guidelines based on the patient’s condition.
机译:尽管正在开发用于优化全血细胞计数结果的自动血液学分析仪,但血小板计数仍然受到分析前或分析缺陷的困扰,包括EDTA引起的假性血小板减少症。尽管这些干扰中的大多数已广为人知,但实验室实践仍然高度异构。为了协调和标准化细胞血液学实践,法语细胞血液学小组(GFHC)希望着眼于可能影响血小板计数的干扰,并以最小限度的建议详细说明验证步骤,同时考虑到当今使用的不同技术。此处提出的GFHC的结论获得了“强烈的专业共识”,并解释了其原理以定义作用过程,以防万一发现血小板减少症或血小板增多症。这些建议是最低限度的建议,可供每位实验室医学专家使用,他们可以根据患者的病情自由使用更具限制性的指南。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号